CAPR

CAPRICOR THERAPEUTICS, INC.

Biotechnology · Biotechnology

$254.55 sample

+4.06 (+1.62%) 1D

Market cap

$553.7B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-30

Alerts

8

Price$254.55 -7.63% 3M daily closessample

280.59244.57

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider sell: General Counsel
Sep 30SECDEF 14A filed
Sep 22INSInsider sell: 10% owner
Sep 17INSInsider sell: EVP, Operations
Sep 10INSInsider sell: General Counsel
Sep 07INSInsider sell: 10% owner
Aug 28SEC8-K filed: material event
Aug 25INSInsider sell: Director

Sign up to see the real CAPR record →

Company facts

SEC EDGAR registration

Name: CAPRICOR THERAPEUTICS, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +12sample, -100 to +100
Reporting currency: USD

Who is positioning in CAPR

sample

Insiders: 30 insider transactions over 90 days, net selling, $245.6M
Congress: 3 members traded over 90 days
Institutions · 13F: 10 funds hold $5.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$31.4B +16.5% y/y

Q4 2024Q3 2026

Inventory$18.7B +16.0% y/y

Q4 2024Q3 2026

Accounts receivable$13.9B +14.3% y/y

Q4 2024Q3 2026

Total debt$36.8B +10.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $60.6B -3.4% 3M
Sample peer B: $467.6B +15.7% 3M
Sample peer C: $185.0B -8.4% 3M
Sample peer D: $194.0B +5.2% 3M
Sample peer E: $170.6B +2.8% 3M